Blueblood Ventures (BOM:539637) EBIT : ₹0.60 Mil (TTM As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Blueblood Ventures EBIT?

Blueblood Ventures's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2023 was ₹-0.10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.60 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Blueblood Ventures's annualized ROC % for the quarter that ended in Sep. 2023 was -0.07%. Blueblood Ventures's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -0.30%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Blueblood Ventures's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 0.06%.

Blueblood Ventures EBIT Historical Data

The historical data trend for Blueblood Ventures's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueblood Ventures EBIT Chart

Blueblood Ventures Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

-1.68

-11.04

1.20

0.21

0.19

Blueblood Ventures Semi-Annual Data
	Mar15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT	Get a 7-Day Free Trial												1.65	-1.44	-0.52	0.71	-0.10

Competitive Comparison of Blueblood Ventures's EBIT

For the Capital Markets subindustry, Blueblood Ventures's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blueblood Ventures's EV-to-EBIT Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Blueblood Ventures's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Blueblood Ventures's EV-to-EBIT falls into.

Blueblood Ventures EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.60 Mil.

Blueblood Ventures (BOM:539637) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Blueblood Ventures's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	-0.704 * ( 1 - 0% )	/	( (968.642	+	970.981)	/ 2 )
=	-0.704	/	969.8115
=	-0.07 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	971.888	-	2.908	-	( 0.338	-	max(0, 3.554	-	70.206	+	0.338	))
=	968.642

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	971.742	-	0.441	-	( 0.32	-	max(0, 2.498	-	71.13	+	0.32	))
=	970.981

Note: The Operating Income data used here is two times the semi-annual (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Blueblood Ventures's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.202	/	( ( (0.773 + max(65.974, 0))	+	(0.516 + max(68.149, 0)) )	/	2 )
=	-0.202	/	( ( 66.747	+	68.665 )	/	2 )
=	-0.202	/	67.706
=	-0.30 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(66.639	+	2.698	+	0.19100000000002)	-	(2.908	+	0	+	0.646)
=	65.974

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(66.767	+	3.836	+	0.043999999999997)	-	(0.441	+	0	+	2.057)
=	68.149

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Blueblood Ventures's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	0.604	/	972.884
	=	0.06 %

Blueblood Ventures EBIT Related Terms

Thank you for viewing the detailed overview of Blueblood Ventures's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Blueblood Ventures (BOM:539637) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Blueblood Ventures Ltd (BOM:539637) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

M Block Market, M-55, Third Floor, Greater Kailash II, New Delhi, IND, 110048

Website

http://www.bluebloodventure.com

Blueblood Ventures Ltd is engaged in the business of equity investment and trading in equity, derivatives, commodities, futures, and options, as well as other financial products. It also provides management and business consultancy. The company receives revenue from the sale of shares, securities, and commodities.

Blueblood Ventures (BOM:539637) Headlines

No Headlines